QA: vTv Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001641489_2023_vTv_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001641489, vTv Therapeutics Inc.

  xvar xval
0 AssetsCurrent 27,094,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 207,000
3 remainder_Assets 5,937,000
4 LiabilitiesCurrent 7,708,000
5 LiabilitiesNoncurrent 19,007,000
6 remainder_Liabilities 684,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,201,000
9 ResearchAndDevelopmentExpense 12,357,000
10 remainder_Expenses 215,000
11 remainder_Revenues 2,018,000
12 remainder_NetIncome -2,318,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 33,238,000
1 Liabilities 27,399,000
2 Expenses 24,773,000
3 Revenues 2,018,000
4 StockholdersEquity 5,839,000
5 NetIncome -25,073,000
6 ComprehensiveNetIncome -25,073,000
7 BaseVar 44,873,000
8 EconomicCapitalRatio -0.496

Edgar->Model Mapping

Feature Distribution

Change over Time